Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Innopsys' InnoScan 910 Scanner; BioDiscovery's Nexus Copy Number for Affymetrix

Premium

Innopsys has launched its newest microarray scanner, the InnoScan 910 microarray scanner. The two-color fluorescence scanner is capable of reading high-density microarrays with a resolution of 1 micron per pixel. According to the Carboneau, France-based company, the 910 can read two detection channels in under four minutes with a 10 micron per pixel maximum reading area. The system also includes a barcode reader, providing accurate control of the acquired images, and is supplied with a validation slide and the company's Mapix software.


BioDiscovery and Affymetrix have jointly announced the availability of Nexus Copy Number for Affymetrix, a new analysis software designed specifically for data generated by Affymetrix's genetic analysis platforms for cancer research, such as its CytoScan Cytogenetics Suite and its OncoScan FFPE Assay Kit.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.